Molecule Details
InChIKeyTTZSNFLLYPYKIL-UHFFFAOYSA-N
Compound NameSurufatinib
Canonical SMILESCc1cc2cc(Oc3ccnc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)n3)ccc2[nH]1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)7
Pfam Stratification Homologous
Avg pChEMBL8.13
SourceChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB15106
Drug NameSurufatinib
CAS Number1308672-74-3
Groups investigational
ATC Codes L01EX24
DescriptionSurufatinib is under investigation in clinical trial NCT02588170 (Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors).

Categories: Amides Antineoplastic Agents Antineoplastic and Immunomodulating Agents Heterocyclic Compounds, Fused-Ring Protein Kinase Inhibitors Sulfones Sulfur Compounds
Cross-references: ChemSpider: 57583328 PDB: UKI ZINC: ZINC000117218067
Target Activities (7)
Target Gene Organism Category Pfam pChEMBL Type Source
P35916 FLT4 Homo sapiens Human PF07679 PF13927 PF22971 PF07714 PF21339 PF17988 PF22854 9.0 IC50 ChEMBL
P17948 FLT1 Homo sapiens Human PF07679 PF00047 PF13927 PF22971 PF07714 PF21339 PF17988 PF22854 8.8 IC50 ChEMBL
Q12866 MERTK Homo sapiens Human PF00041 PF00047 PF13927 PF07714 8.4 IC50 ChEMBL
P35968 KDR Homo sapiens Human PF07679 PF00047 PF13895 PF22971 PF07714 PF21339 PF17988 PF22854 8.3 IC50 ChEMBL
P11362 FGFR1 Homo sapiens Human PF07679 PF00047 PF07714 7.8 IC50 ChEMBL
Q16620 NTRK2 Homo sapiens Human PF07679 PF13855 PF16920 PF01462 PF07714 7.4 IC50 ChEMBL
P36888 FLT3 Homo sapiens Human PF00047 PF07714 7.2 IC50 ChEMBL
DrugBank Target Actions (5)
Target Gene Target Name Action Type
P07333 CSF1R Macrophage colony-stimulating factor 1 receptor inhibitor targets
P11362 FGFR1 Fibroblast growth factor receptor 1 inhibitor targets
P17948 FLT1 Vascular endothelial growth factor receptor 1 inhibitor targets
P35916 FLT4 Vascular endothelial growth factor receptor 3 inhibitor targets
P35968 KDR Vascular endothelial growth factor receptor 2 inhibitor targets